APA (7th ed.) Citation

Schlenk, R. F. (2024). Genetics as predictive marker for consolidation therapy with high-dose cytarabine in acute myeloid leukemia. Haematologica, 109(6), . https://doi.org/10.3324/haematol.2024.285624

Chicago Style (17th ed.) Citation

Schlenk, Richard Friedrich. "Genetics as Predictive Marker for Consolidation Therapy with High-dose Cytarabine in Acute Myeloid Leukemia." Haematologica 109, no. 6 (2024). https://doi.org/10.3324/haematol.2024.285624.

MLA (9th ed.) Citation

Schlenk, Richard Friedrich. "Genetics as Predictive Marker for Consolidation Therapy with High-dose Cytarabine in Acute Myeloid Leukemia." Haematologica, vol. 109, no. 6, 2024, https://doi.org/10.3324/haematol.2024.285624.